Menu
Back to Journals » Drug Design, Development and Therapy » Volume 15
Corrigendum
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,578 | Dovepress* | 3,386+ | 419 | 3,805 | |
| PubMed Central* | 192 | 79 | 271 | ||
| Totals | 3,578 | 498 | 4,076 | ||
| *Since 12 February 2021 | |||||
View citations on PubMed Central and Google Scholar